Latest Blog Roll

Roche to invest $555M on Indian biotech company's immuno-oncology drug

Roche inked a deal worth up to $555 million to work with India's Curadev Pharma for the development and commercialization of IDO1 and TDO inhibitors used for cancer treatments.

Stempeutics Gets Stem Cell Patent in China for its Novel Stem Cell Drug 'Stempeucel'

Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced that the State Intellectual Property Office of China (SIPO) granted a pr